Impact of fluorine-18 fluorodeoxyglucose positron emission tomography on diagnosis and antimicrobial utilization in patients with high-risk febrile neutropenia

Leukemia and Lymphoma

Volumn 53, Issue 10, 2012, Pages 1889-1895

  Koh, Kwee Choy ^a   Slavin, Monica A ^b   Thursky, Karin A ^b   Lau, Eddie ^c   Hicks, Rodney J ^c   Drummond, Elizabeth ^c   Wong, Peng Shyan ^d   Worth, Leon J ^b  

^a INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

^b Department of Infectious Diseases ^*  (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

^d Penang Hospital   (Malaysia)

Author keywords

FDG PET; Febrile neutropenia; Hematological malignancy; Infection

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUORODEOXYGLUCOSE F 18; GENTAMICIN; PIPERACILLIN PLUS TAZOBACTAM; POSACONAZOLE; VANCOMYCIN; VORICONAZOLE;

ANTIMICROBIAL THERAPY; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG USE; FEBRILE NEUTROPENIA; HUMAN; IMAGING; INFECTION RISK; LENGTH OF STAY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROPHYLAXIS; SYSTEMIC MYCOSIS; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; ANTIBIOTIC PROPHYLAXIS; CASE-CONTROL STUDIES; FEMALE; FEVER; FLUORODEOXYGLUCOSE F18; HEMATOLOGIC NEOPLASMS; HUMANS; INDUCTION CHEMOTHERAPY; MALE; MIDDLE AGED; NEOPLASM STAGING; NEUTROPENIA; POSITRON-EMISSION TOMOGRAPHY; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RISK; YOUNG ADULT;

EID: 84865724443     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2012.677533     Document Type: Article

References (16)

1. S, Thursky KA, Slavin MA, et al. The disease andeconomic burden of neutropenic fever in adult patients in Australian cancer treatment centres 2008: analysis of the Victorian Admitted Episodes Dataset. Intern Med J2011;41:121-129.
2. Kuderer NM, Dale DC, Crawford J, et al. Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer 2006;106:2258-2266.
3. de Naurois J, Novitzky-Basso I, Gill MJ, et al. Management of febrile neutropenia: ESMOClinical Practice Guidelines. Ann Oncol 2010;21:252-256.
4. Kumar R, Basu S, Torigian D, et al. Role of modern imaging techniques for diagnosis of infection in the era of 18F-fluorodeoxyglucose positron emission tomography. Clin Microbiol Rev 2008;21:209-224.
5. Ergul N, Cermik TF. FDG-PETor PET/CTin fever of unknown origin: the diagnostic role of underlying primary disease. Int JMol Imaging 2011;2011:318051.
6. Balink H, Collins J, Bruyn GA, et al. F-18 FDGPET/CTin the diagnosis of fever of unknown origin. Clin Nucl Med 2009;34:862-868.
7. Kubota K, Nakamoto Y, Tamaki N, et al. FDG-PETfor the diagnosis of fever of unknown origin: a Japanese multi-center study. Ann Nucl Med 2011;25:355-364.
8. Basu S, Chryssikos T, Moghadam-Kia S, et al. Positron emission tomography as a diagnostic tool in infection: present role and future possibilities. Semin Nucl Med 2009;39:36-51.
9. Wong PS, Lau WE, Worth LJ, et al. Clinically important detection of infection as an " incidental " finding during cancer staging using FDG-PET/CT. Intern Med J2012;42:176-183.
10. Guy SD, Tramontana AR, Lau E, et al. 18Ffluorodeoxyglucose positron emission tomography computerised tomography (FDG-PETCT) scanning in persistent febrile neutropenia; a pilot study. Paper presented at 20th European Congress of Clinical Microbiology and Infectious Diseases. 10-13 April 2010. Vienna.
11. Mahfouz T, Miceli MH, Saghafifar F, et al. 18F-fluorodeoxyglucose positron emission tomography contributes to the diagnosis and management of infections in patients with multiple myeloma: a study of 165 infectious episodes. JClin Oncol 2005;23:7857-7863.
12. Xu B, Shi P, Wu H, et al. Utility of FDGPET/CTin guiding antifungal therapy in acute leukemia patients with chronic disseminated candidiasis. Clin Nucl Med 2010;35:567-570.
13. Tam CS, O'Reilly M, Andresen D, et al. Use of empiric antimicrobial therapy in neutropenic fever. Intern Med J2011;41:90-101.
14. Hot A, Maunoury C, Poiree S, et al. Diagnostic contribution of positron emission tomography with [18F] fluorodeoxyglucose for invasive fungal infections. Clin Microbiol Infect 2011;17:409-417.
15. Bleeker-Rovers CP, Vos FJ, de Kleijn EM, et al. Aprospective multicenter study on fever of unknown origin:the yield of a structured diagnostic protocol. Medicine (Baltimore) 2007;86:26-38.
16. De Winter F, Vogelaers D, Gemmel F, et al. Promising role of 18-F-fluoro-D-deoxyglucose positron emission tomography in clinical infectious diseases. Eur JClin Microbiol Infect Dis 2002;21: 247-257.